Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

Cancer combination therapies by angiogenesis inhibitors; a comprehensive review

Abstract Abnormal vasculature is one of the most conspicuous traits of tumor tissue, largely contributing to tumor immune evasion. The deregulation mainly arises from the potentiated pro-angiogenic factors secretion and can also target immune cells' biological events, such as migration and acti...

Full description

Bibliographic Details
Main Authors: Mohammad Javed Ansari, Dmitry Bokov, Alexander Markov, Abduladheem Turki Jalil, Mohammed Nader Shalaby, Wanich Suksatan, Supat Chupradit, Hasan S. AL-Ghamdi, Navid Shomali, Amir Zamani, Ali Mohammadi, Mehdi Dadashpour
Format: Article
Language:English
Published: BMC 2022-04-01
Series:Cell Communication and Signaling
Subjects:
Angiogenesis
Tumor
Anti-angiogenic agents
Combination therapy
Resistance
Online Access:https://doi.org/10.1186/s12964-022-00838-y

Internet

https://doi.org/10.1186/s12964-022-00838-y

Similar Items